CALABRO', FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 134
EU - Europa 79
AS - Asia 73
SA - Sud America 1
Totale 287
Nazione #
US - Stati Uniti d'America 131
CN - Cina 60
IE - Irlanda 52
FI - Finlandia 15
SG - Singapore 12
DE - Germania 10
CA - Canada 3
GB - Regno Unito 1
IR - Iran 1
IT - Italia 1
PE - Perù 1
Totale 287
Città #
Dublin 52
Chandler 36
Beijing 21
Helsinki 14
Ashburn 9
Nanjing 9
Singapore 9
Wilmington 8
Boardman 7
Lawrence 7
Medford 7
Piscataway 7
Princeton 7
Shanghai 7
New York 6
Shenyang 5
Changsha 4
Hangzhou 3
Nanchang 3
Toronto 3
Dearborn 2
Falkenstein 2
Hebei 2
Jiaxing 2
Cambridge 1
Dallas 1
Fairfield 1
Fuzhou 1
Houston 1
Jacksonville 1
Lima 1
London 1
Pavia 1
Tianjin 1
Washington 1
Zhengzhou 1
Totale 244
Nome #
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 53
Fast formation of isogeometric Galerkin matrices by weighted quadrature 47
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 47
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 46
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 43
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: Final results from an expanded-access trial 36
Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors 31
Totale 303
Categoria #
all - tutte 1.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.665


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 2 2 4 5 12 0
2020/20219 0 0 0 0 5 1 0 3 0 0 0 0
2021/202230 0 0 3 0 0 0 0 2 0 0 6 19
2022/2023117 15 10 4 3 9 8 0 4 60 0 4 0
2023/202445 7 7 1 0 3 13 1 2 0 0 10 1
2024/202532 5 8 4 1 2 12 0 0 0 0 0 0
Totale 303